Attachment 8
Laboratory Assessment 2025-2026 and Earlier
Attachment 8: Laboratory Assessment 2025-2026 and Earlier
NCEH MASTER LIST OF ANALYTES TABLE LEGEND |
|
|
Empty cell indicates that the analyte was not measured or reported to NCHS during that cycle |
● |
Measured during cycle and reported to NCHS via data file submission, or measurement is planned for future NHANES survey |
P |
Sample was pooled during cycle |
Surplus |
Measurement of analyte originally planned for regular NHANES but later converted to surplus sample request during cycle, per NCHS |
& Surplus |
Table data published in exposure report as regular sample and as surplus sample (updated data, children only data, etc.) |
NO PRBC |
No Packed Red Blood Cells (PRBC) available during cycle |
C |
Measuring is contingent upon funding and other resources during cycle |
X1 |
Measured but not reported, as MECs were contaminated with those analytes |
WD |
Analyte/chemical originally intended to be measured and withdrawn during cycle; please follow up with branch for description |
D |
Dropped during cycle/cycled out; unless otherwise stated, most common reason is no detection |
DEV |
Method in development during cycle |
Strikethrough |
Analyte methodology discontinued/dropped for methods issues; included in table for archival purposes |
x |
Was not approved by NCHS |
♀ |
Female |
♂ |
Male |
{Analyte} Isomer |
Refer to one of the isomer associated with specified analyte |
Analyte/Chemical/Metabolite |
Measured Matrix |
Sample
Cycle |
Sample Cycle > 25-26 |
11-12 |
13-14 |
15-16 |
17-18 |
19-20 |
21-23 |
25-26 |
|
Formaldehyde |
PRBC |
Full set, then 1/3 |
Full set, then 1/2 |
|
● |
● |
D |
D |
D |
|
|
Acrylamide |
NO PRBC |
● |
● |
D |
D |
D |
|
||||
Glycidamide |
● |
● |
D |
D |
D |
|
|||||
Ethylene Oxide |
|
● |
● |
● |
● |
D |
|
||||
Acrylonitrile |
1/3 of 6+ |
1/2 of 5+ |
|
|
|
|
|
● |
|
||
Sex Steroid Hormones (Reproductive Hormones) |
|
|
|
|
|
|
|
|
|
||
Estradiol, Total (E2) |
Serum |
Proposed 6+, only this Analyte 2–4 |
Proposed: 5+ , only this Analyte 2-4 |
|
● |
● |
Surplus |
● |
● |
|
|
Steroid Hormone–Binding Globulin (SHBG) |
|
● |
● |
Surplus |
● |
● |
|
||||
Testosterone, Total (TT) |
● |
● |
● |
x |
● |
● |
|
||||
17α-Hydroxyprogesterone (17-OHP) / Hydroxyprogesterone |
|
|
|
Surplus |
● |
● |
|
||||
Progesterone (P4) |
|
|
|
Surplus |
● |
● |
|
||||
Estrone (E1) |
|
|
|
Surplus |
● |
● |
|
||||
Estrone sulfate (E1S) |
|
|
|
Surplus |
● |
● |
|
||||
Androstenedione (AD) |
|
|
|
Surplus |
● |
● |
|
||||
Dehydroepiandrosterone sulfate (DHEAS) |
|
|
|
x |
● |
● |
|
||||
Anti-Müllerian hormone (AMH) |
♀ 6+ |
,♀ 5+ |
|
|
|
Surplus |
● |
● |
|
||
Follicle-stimulating hormone (FSH) |
6+ |
5+ |
|
|
|
Surplus |
● |
● |
|
||
Luteinizing hormone (LH) |
|
|
|
Surplus |
● |
● |
|
||||
Trans Fatty Acids |
|
|
|
|
|
|
|
|
|
|
|
trans-9-Hexadecenoic acid |
Plasma |
1/3 of 3+ |
1/2 of 3+ |
D |
|
|
|
|
● |
|
|
trans-9-Octadecenoic acid |
D |
|
|
|
|
● |
|
||||
trans,trans-9,12-Octadecadienoic acid |
D |
|
|
|
|
● |
|
||||
trans-11-Octadecanoic acid |
D |
|
|
|
|
● |
|
||||
Thyroid Function |
|
|
|
|
|
|
|
|
|
|
|
Free thyroxine (FT4) |
Serum |
N/A |
TBA |
|
|
|
|
|
|
● |
|
Total thyroxine (TF4) |
|
|
|
|
|
|
● |
||||
Thyroid peroxidase antibodies |
|
|
|
|
|
|
● |
||||
Thyroglobulin antibodies |
|
|
|
|
|
|
● |
||||
Thyroid-stimulating hormone (TSH) |
|
|
|
|
|
|
● |
||||
(TSH) receptor antibodies |
|
|
|
|
|
|
● |
||||
Thyroglobulin * |
|
|
|
|
|
|
C |
||||
Free T3 * -Triiodothyronine |
|
|
|
|
|
|
C |
||||
Total T3 * -Triiodothyronine |
|
|
|
|
|
|
● |
||||
Fructose (CT) |
|
|
|
|
|
|
● |
||||
Cholinesterase Assays in Blood and Serum |
|
|
|
|
|
|
|
||||
RBC Acetylcholinesterase activity (AChE activity) |
Whole Blood |
Full Set, 6+ |
Full Set, 5+ |
|
|
|
|
x |
● |
|
|
Butyrylcholinesterase activity (BChE activity) |
Serum |
|
|
|
|
|
● |
● |
|||
Butyrylcholinesterase concentration (BChE) |
|
|
|
|
|
● |
● |
||||
Chlorinated Tyrosines |
|
|
|
|
|
|
|
||||
Serum 3-chlorotyrosine |
Serum |
6+ |
5+ |
|
|
● |
|
x |
|
|
|
Serum 3,5-dichlorotyrosine |
|
|
● |
|
|
|
|
||||
Metals and Metalloids |
|
|
|
|
|
|
|
||||
Antimony |
|
Urine |
3–5 & 1/3 of 6+ |
3–4 & 1/2 of 5+ |
● |
● |
● |
● |
● |
● |
● |
Arsenic (total) |
|
● |
● |
● |
● |
● |
● |
● |
|||
Arsenic (V) acid |
|
● |
● |
● |
● |
● |
● |
● |
|||
Arsenobetaine |
|
● |
● |
● |
● |
● |
● |
● |
|||
Arsenocholine |
|
● |
● |
● |
● |
● |
● |
● |
|||
Arsenous (III) acid |
|
● |
● |
● |
● |
● |
● |
● |
|||
Dimethylarsinic acid |
|
● |
● |
● |
● |
● |
● |
● |
|||
Monomethylarsonic acid |
|
● |
● |
● |
● |
● |
● |
● |
|||
Trimethylarsine oxide |
|
● |
D |
|
|
|
|
|
|||
Barium |
|
● |
● |
● |
● |
● |
● |
● |
|||
Beryllium |
|
D |
|
|
|
|
|
|
|||
Cadmium |
|
Whole Blood |
Full; 1/2 (13–14) |
1+ |
● |
● |
● |
● |
● |
● |
|
Cadmium |
|
Urine |
3–5 & 1/3 of 6+ |
3-4 & 1/2 of 5+ |
● |
● |
● |
● |
● |
● |
● |
Cesium |
|
● |
● |
● |
● |
● |
● |
● |
|||
Chromium |
|
|
|
|
● |
● |
● |
● |
|||
Chromium |
|
Whole Blood |
40+ |
1+ |
|
|
● |
● |
D |
|
|
Cobalt |
|
|
|
|
|
● |
● |
D |
|
|
|
Cobalt |
|
Urine |
3–5 & 1/3 of 6+ |
3–4 & 1/2 of 5+ |
● |
● |
● |
● |
● |
● |
● |
Copper |
|
Serum |
1/3 of 12+ |
1/2 of 12+ |
● |
● |
● |
D |
|
|
|
Lead |
|
Urine |
3–5 & 1/3 of 6+ |
3–4 & 1/2 of 5+ |
● |
● |
● |
● |
● |
● |
● |
Lead |
|
Whole Blood |
Full; 1/2 (13–14) |
Full; 1+ |
● |
● |
● |
● |
● |
● |
● |
Manganese |
|
Full; 1/2 (13–14) |
1+ |
● |
● |
● |
● |
● |
● |
● |
|
Manganese |
|
Urine |
3–5 & 1/3 of 6+ |
3-4 & 1/2 5+ |
● |
● |
● |
● |
● |
● |
|
Mercury (total) |
|
Whole Blood |
Full; 1/2 (13–14) |
1+ |
● |
● |
● |
● |
● |
● |
● |
Mercury (inorganic) |
Urine |
|
|
● |
● |
● |
● |
● |
● |
● |
|
Mercury (ethyl) |
|
|
|
|
● |
● |
● |
● |
● |
● |
● |
Mercury (methyl) |
|
|
|
● |
● |
● |
● |
● |
● |
● |
|
Mercury |
|
3–5 & 1/3 of 6+ |
3-4 & 1/2 of 5+ |
● |
● |
● |
● |
● |
● |
● |
|
Molybdenum |
|
|
|
● |
● |
● |
● |
● |
● |
● |
|
Nickel |
|
|
|
|
|
|
● |
● |
● |
● |
|
Platinum |
|
|
|
D |
|
|
|
|
|
|
|
Selenium |
|
Whole Blood |
Full; 1/2 (13–14) |
Full; 1/2 (13-14) |
● |
● |
● |
● |
● |
● |
● |
Selenium |
|
Serum |
1/3 of 12+ |
1/2 of 12+ |
● |
● |
● |
D |
|
|
|
Strontium |
|
Urine |
3–5 & 1/3 of 6+ |
3–4 & 1/2 of 5+ |
● |
● |
● |
● |
● |
● |
● |
Thallium |
|
|
|
● |
● |
● |
● |
● |
● |
● |
|
Tin |
|
|
|
● |
● |
● |
● |
● |
● |
● |
|
Tungsten |
|
|
|
● |
● |
● |
● |
● |
● |
● |
|
Uranium |
|
|
|
● |
● |
● |
● |
● |
● |
|
|
Zinc |
|
Serum |
1/3 of 12+ |
1/2 of 12+ |
● |
● |
● |
D |
|
|
|
Iodine |
|
Urine |
3–5 & 1/3 of 6+ |
3–4 & 1/2 of 5+ |
● |
● |
● |
● |
● |
● |
● |
Iodine |
|
Salt |
|
|
|
|
|
|
● |
D |
|
Iodine |
|
Salt |
|
|
|
|
|
|
● |
D |
|
Fluoride |
|
Water |
0–19 & MEC examined |
0–17 & MEC examined |
|
|
|
|
● |
D |
|
Fluoride |
|
Urine |
6-19 |
5-19 |
|
● |
● |
D |
|
|
|
Caffeine and Metabolites |
|
|
|
|
|
|
|
|
|
|
|
5-acetylamino-6-amino-3-methyluracil |
Urine |
6+ |
N/A |
● |
● |
D |
|
|
|
|
|
1-methyluric acid |
● |
● |
D |
|
|
|
|
||||
3-methyluric acid |
● |
● |
D |
|
|
|
|
||||
7-methyluric acid |
● |
● |
D |
|
|
|
|
||||
1,3-dimethyluric acid |
● |
● |
D |
|
|
|
|
||||
1,7-dimethyluric acid |
● |
● |
D |
|
|
|
|
||||
3,7-dimethyluric acid |
● |
● |
D |
|
|
|
|
||||
1,3,7-trimethyluric acid |
|
|
● |
● |
D |
|
|
|
|
||
1-methylxanthine |
|
● |
● |
D |
|
|
|
|
|||
3-methylxanthine |
|
● |
● |
D |
|
|
|
|
|||
7-methylxanthine |
● |
● |
D |
|
|
|
|
||||
1,3-dimethylxanthine (theophylline) |
● |
● |
D |
|
|
|
|
||||
1,7-dimethylxanthine (paraxanthine) |
● |
● |
D |
|
|
|
|
||||
3,7-dimethylxanthine (theobromine) |
● |
● |
D |
|
|
|
|
||||
1,3,7-trimethylxanthine (caffeine) |
|
|
● |
● |
D |
|
|
|
|
||
Fatty acids (30) |
|
|
|
|
|
|
|
|
|
|
|
Capric acid (C10:0) |
|
Plasma /Serum |
NH11–14 3+ & 12+ fasting |
N/A |
● |
● |
D |
|
|
|
|
Lauric acid (C12:0) |
|
● |
● |
D |
|
|
|
|
|||
Myristic acid (14:0) |
|
● |
● |
D |
|
|
|
|
|||
Pentadecanoic acid (C15:0) |
|
● |
● |
D |
|
|
|
|
|||
Palmitic acid (16:0) |
|
● |
● |
D |
|
|
|
|
|||
Margaric acid (C17:0) |
|
● |
● |
D |
|
|
|
|
|||
Stearic acid (18:0) |
|
● |
● |
D |
|
|
|
|
|||
Arachidic acid (20:0) |
|
● |
● |
D |
|
|
|
|
|||
Docosanoic acid (22:0) |
|
● |
● |
D |
|
|
|
|
|||
Tricosanoic acid (C23:0) |
|
● |
● |
D |
|
|
|
|
|||
Lignoceric acid (24:0) |
|
● |
● |
D |
|
|
|
|
|||
Myristoleic acid (14:1n-5) |
|
● |
● |
D |
|
|
|
|
|||
Palmitoleic acid (16:1n-7) |
|
● |
● |
D |
|
|
|
|
|||
cis-Vaccenic acid (18:1n-7) |
|
● |
● |
D |
|
|
|
|
|||
Oleic acid (18:1n-9) |
|
● |
● |
D |
|
|
|
|
|||
Eicosenoic acid (20:1n-9) |
|
● |
● |
D |
|
|
|
|
|||
Docosenoic acid (22:1n-9) |
|
D |
|
|
|
|
|
|
|||
Nervonic acid (24:1n-9) |
|
● |
● |
D |
|
|
|
|
|||
Linoleic acid (18:2n-6) |
|
● |
● |
D |
|
|
|
|
|||
alpha-Linolenic acid (18:3n-3) |
|
● |
● |
D |
|
|
|
|
|||
gamma-Linolenic acid (18:3n-6) |
|
● |
● |
D |
|
|
|
|
|||
Stearidonic acid (C18:4n-3) |
|
● |
● |
D |
|
|
|
|
|||
Eicosadienoic acid (20:2n-6) |
|
● |
● |
D |
|
|
|
|
|||
homo-gamma-Linolenic acid (20:3n-6) |
● |
● |
D |
|
|
|
|
||||
Eicosatrienoic acid (C20:3n-9) |
● |
● |
D |
|
|
|
|
||||
Arachidonic acid (20:4n-6) |
● |
● |
D |
|
|
|
|
||||
Eicosapentaenoic acid (20:5n-3) |
● |
● |
D |
|
|
|
|
||||
Docosatetraenoic acid (22:4n-6) |
● |
● |
D |
|
|
|
|
||||
Docosapentaenoic acid (22:5n-3) |
● |
● |
D |
|
|
|
|
||||
Docosapentaenoic acid (22:5n-6) |
● |
● |
D |
|
|
|
|
||||
Docosahexaenoic acid (22:6n-3) |
● |
● |
D |
|
|
|
|
||||
Fatty acids in RBCs (NBB) |
|
|
|
|
|
|
|
|
|||
% alpha-Linolenic acid (C18:3n3) |
RBC |
6+ |
5+ |
|
|
|
|
● |
● |
|
|
% Arachidic acid (C20:0) |
|
|
|
|
|
|
|
● |
● |
|
|
% Arachidonic acid (C20:4n6) |
|
|
|
|
|
|
|
● |
● |
|
|
% Docosanoic acid (C22:0) |
|
|
|
|
|
|
|
● |
● |
|
|
% Docosahexaenoic acid (C22:6n3) |
|
|
|
|
|
|
|
● |
● |
|
|
% Docosapentaenoic acid 3 (C22:5n3) |
|
|
|
|
|
|
|
● |
● |
|
|
% Docosapentaenoic acid 6 (C22:5n6) |
|
|
|
|
|
|
|
● |
● |
|
|
% Docosatetraenoic acid (C22:4n6)
|
|
|
|
|
|
|
|
● |
● |
|
|
% Docosatetraenoic acid (C22:4n6)
|
|
|
|
|
|
|
|
● |
● |
|
|
% 11-Eicosenoic acid (C20:1n9) |
|
|
|
|
|
|
|
● |
● |
|
|
% Eicosapentaenoic acid (C20:5n3)
|
|
|
|
|
|
|
|
● |
● |
|
|
% gamma-Linolenic acid (C18:3n6) |
|
|
|
|
|
|
|
● |
● |
|
|
% homo-gamma-Linolenic acid (C20:3n6) |
|
|
|
|
|
|
|
|
● |
● |
|
% Tetracosanoic acid (C24:0) |
|
|
|
|
|
|
|
|
● |
● |
|
% Linoleic acid (C18:2n6) |
|
|
|
|
|
|
|
|
● |
● |
|
% Myristic acid (C14:0) |
|
|
|
|
|
|
|
|
● |
● |
|
% 15-Tetracosenoic acid (C24:1n9) |
|
|
|
|
|
|
|
● |
● |
|
|
% Oleic acid (C18:1n9) |
|
|
|
|
|
|
|
|
● |
● |
|
% Palmitoleic acid (C16:1n7) |
|
|
|
|
|
|
|
● |
● |
|
|
% Palmitic acid (C16:0) |
|
|
|
|
|
|
|
|
● |
● |
|
% Stearic acid (C18:0) |
|
|
|
|
|
|
|
● |
● |
|
|
Fat-Soluble Vitamins and Micronutrients |
|
|
|
|
|
|
|
||||
Vitamin A |
|
Serum |
NH17–18: 6+ |
5+ |
|
|
|
● |
D |
C |
|
Vitamin E |
|
N/A |
|
|
|
● |
D |
|
|
||
Retinyl palmitate |
|
|
|
|
● |
D |
|
|
|||
Retinyl stearate |
|
|
|
|
● |
D |
|
|
|||
Gamma-Tocopherol |
|
|
|
|
● |
D |
|
|
|||
delta-Tocopherol |
|
|
|
|
|
|
|
||||
alpha-carotene |
|
|
|
● |
D |
|
|
||||
Trans-beta-carotene |
|
|
|
|
|
● |
D |
|
|
||
Cis-beta-carotene |
|
|
|
|
● |
D |
|
|
|||
alpha-Cryptoxanthin |
|
|
|
|
● |
D |
|
|
|||
beta-Cryptoxanthin |
|
|
|
● |
D |
|
|
||||
Lutein/zeaxanthin combined or measured and reported as separate analytes |
|
|
|
● |
D |
|
|
||||
trans-Lycopene |
|
|
|
|
|
● |
D |
|
|
||
Total lycopene |
|
|
|
|
● |
D |
|
|
|||
25-OH Vitamin D (D2 + D3) |
|
|
5+ |
● |
● |
● |
● |
D |
C |
|
|
25-OH Vitamin D2 |
|
● |
● |
● |
● |
D |
C |
|
|||
25-OH Vitamin D3 |
|
● |
● |
● |
● |
D |
C |
|
|||
epimer-25-OH Vitamin D3 |
|
● |
● |
● |
● |
D |
C |
|
|||
Iron-Status and Inflammation Indicators |
|
|
|
|
|
|
|||||
Ferritin |
|
Serum |
NH03–16: 1–5 & ♀ 12–49 NH17–20: 1–5 & 12+ |
1-5 & 12+ |
D |
|
Surplus |
Surplus |
● |
C |
|
Transferrin receptor |
|
NH03–16: 1–5 & ♀ 12–49 NH17–18: 1–5 & 12+ NH19–20: 1–5y & ♀ 12–49 |
1-5 & ♀ 12-49 |
D |
|
● |
● |
● |
C |
|
|
Alpha-acid-1-glycoprotein |
NH15–18: 1–5 & ♀ 12–49 |
|
|
● |
● |
|
C |
|
|||
Iron |
|
|
1/3 |
1/2 |
|
|
|
|
|
|
|
TIBC |
|
|
|
|
|
|
|
|
|||
Transferrin saturation |
|
|
|
|
|
|
|
|
|||
Protoporphyrin |
|
|
|
|
|
|
|
|
|
||
Phytoestrogens and Metabolites |
|
|
|
|
|
|
|
||||
Daidzein |
|
Urine |
6+ |
N/A |
D |
|
|
|
|
|
|
Enterodiol |
|
D |
|
|
|
|
|
|
|||
Enterolactone |
|
D |
|
|
|
|
|
|
|||
Equol |
|
|
D |
|
|
|
|
|
|
||
Genistein |
|
D |
|
|
|
|
|
|
|||
O-Desmethylangolensin |
|
D |
|
|
|
|
|
|
|||
Water-Soluble Vitamins and Related Compounds |
|
|
|
|
|
|
|
|
|||
Folate (Serum) |
Serum |
1+ |
N/A |
D |
|
|
|
|
|
|
|
Folate (RBC) |
RBC |
NH11–16: 1+ NH17–20: ♀ 12–49; 1/2 (♂ 1+, ♀ 1–11 & 50+) |
♀ 12–49 ; 1/2 (♂ 1+, ♀ 1–11 & 50+) |
● |
● |
● |
● |
● |
C |
|
|
Total folate (calculated) |
● |
● |
● |
● |
● |
C |
|
||||
5-Methyltetrahydrofolate |
|
● |
● |
● |
● |
● |
C |
|
|||
Folic acid |
|
● |
● |
● |
● |
● |
C |
|
|||
5-Formyltetrahydrofolate |
|
● |
● |
● |
● |
● |
C |
|
|||
Tetrahydrofolate |
|
● |
● |
● |
● |
● |
C |
|
|||
5,10-Methenyltetrahydrofolate |
|
● |
● |
● |
● |
● |
C |
|
|||
MeFox oxidation product |
|
● |
● |
● |
● |
● |
C |
|
|||
Folate forms by LC-MS/MS |
Serum |
1/3 |
1/2 |
|
|
|
|
|
|
|
|
Folate forms by LC-MS/MS (RBC) |
|
1/3 |
|
|
|
|
|
|
|
||
Total folate (calculated) |
RBC |
NH19–20: 6+ |
5+ |
|
|
|
|
● |
C |
|
|
5-Methyltetrahydrofolate |
|
|
|
|
● |
C |
|
||||
Folic acid |
|
|
|
|
● |
C |
|
||||
5-Formyltetrahydrofolate |
|
|
|
|
● |
C |
|
||||
Ttrahydrofolate |
|
|
|
|
● |
C |
|
||||
5,10-Methenyltetrahydrofolate |
|
|
|
|
● |
C |
|
||||
MeFox oxidation product |
|
|
|
|
● |
C |
|
||||
Homocysteine |
Plasma |
20+ |
N/A |
|
|
|
|
|
|
|
|
Methylmalonic acid |
Plasma/ Serum |
3+ |
5+ |
● |
● |
D |
|
|
|
● |
|
Vitamin B12 |
Serum |
20+ |
● |
● |
D |
|
|
|
● |
||
Vitamin B6 (pyridoxal-5'-phosphate) |
1+ |
D |
|
|
|
|
|
● |
|||
Vitamin B6 (4-pyridoxic acid) |
|
D |
|
|
|
|
|
● |
|||
Vitamin C (ascorbic acid) |
NH17–18: 6+ |
|
|
|
|
● |
D |
C |
|
||
Vitamin D |
|
|
|
|
|
|
|
|
|||
Personal Care and Consumer Product Chemicals and Metabolites |
|
|
|
|
|
|
|
||||
Benzophenone-3 |
Urine |
1/3 |
3–4 & 1/2 of 5+ |
● |
● |
● |
● |
● |
● |
|
|
Bisphenol A |
● |
● |
● |
● |
● |
● |
|
||||
Bisphenol F |
|
● |
● |
● |
● |
● |
|
||||
Bisphenol S |
|
● |
● |
● |
● |
● |
|
||||
Triclocarban |
|
● |
● |
● |
● |
● |
|
||||
4-tert-Octyl phenol |
D |
|
|
|
|
|
|
||||
Triclosan |
● |
● |
● |
● |
● |
● |
|
||||
Butyl paraben |
● |
● |
● |
● |
● |
● |
|
||||
Hydroxy Butyl paraben |
|
|
|
Surplus |
● |
● |
|
||||
Ethyl paraben |
● |
● |
● |
● |
● |
● |
|
||||
Methyl paraben |
● |
● |
● |
● |
● |
● |
|
||||
n-Propyl paraben |
● |
● |
● |
● |
● |
● |
|
||||
Di-hydroxy avobenzone |
|
|
|
Surplus |
● |
● |
|
||||
2,4-Dichlorophenol |
● |
● |
● |
● |
● |
● |
|
||||
2,5-Dichlorophenol |
● |
● |
● |
● |
● |
● |
|
||||
Flame-Retardant Metabolites |
|
|
|
|
|
|
|
|
|
|
|
Bis(1-chloro-2-propyl) phosphate (BCPP) |
Urine |
1/3 |
3–4 & 1/2 of 5+ |
Surplus |
Surplus |
|
Surplus |
● |
● |
|
|
Bis(2-chloroethyl) phosphate (BCEtP) |
|
|
|
Surplus |
● |
● |
|
||||
Bis(1,3-dichloro-2-propyl) phosphate (BDCPP) |
|
|
|
Surplus |
● |
● |
|
||||
Dibenzyl phosphate (DBzP) |
|
|
|
Surplus |
D |
|
|
||||
Dibutyl phosphate (DBuP) |
|
|
|
Surplus |
● |
● |
|
||||
Di-o-cresylphosphate (DoCP) |
|
|
|
|
|
|
|
||||
Di-p-cresylphosphate (DpCP) |
|
|
|
|
|
|
|
||||
Di-cresyl phosphate (DCP) |
Surplus |
|
Surplus |
D |
D |
|
|
||||
Diphenyl phosphate (DPhP) |
|
Surplus |
Surplus |
Surplus |
● |
● |
|
||||
2,3,4,5-Tetrabromobenzoic acid (TBBA) |
|
Surplus |
Surplus |
Surplus |
● |
● |
|
||||
2-((isopropyl)phenyl) phenyl phosphate (iPPPP) |
|
|
Surplus |
Surplus |
|
● |
|
||||
4-((tert-butyl)phenyl)phenyl phosphate (tBPPP) |
|
|
Surplus |
Surplus |
|
● |
|
||||
Bis(2-butoxyethyl) phosphate (BBOEP) |
1/2 |
|
|
|
|
|
|
● |
|||
Bis(2-butoxyethyl) 2-hydroxyethyl phosphate (BBOEHEP) |
|
|
|
|
|
|
● |
||||
Bis(2-butoxyethyl) [(3-hydroxybutyl)oxy]ethyl phosphate (3HO-TBOEP) |
|
|
|
|
|
|
● |
||||
2-ethylhexyl phenyl phosphate (EHPHP) |
|
|
|
|
|
|
● |
||||
2-ethyl-5-hydroxyhexyl diphenyl phosphate (5HO-EHDPP) |
|
|
|
|
|
|
● |
||||
1-hydroxy-2-propyl bis(1-chloro-2-propyl) phosphate (BCIPHIPP) |
|
|
|
|
|
|
● |
||||
Tris(2-chloroethyl)phosphate (TCEtP) |
|
|
|
|
|
|
● |
||||
Dibutyl 3-Hydroxybutyl Phosphate (3HO-TBuP) |
|
|
|
|
|
|
● |
||||
Di isobutyl phosphate (DiBuP) |
|
|
|
|
|
|
● |
||||
4-Hydroxyphenyl diphenyl phosphate (4HO-DPhP) |
|
|
|
|
|
|
● |
||||
2-(2-Methylphenoxy)-4H-1,3,2-benzodioxaphosphorin 2-oxide (CBDP) |
|
|
|
|
|
|
● |
||||
Fungicides and Metabolites (OAT) |
|
|
|
|
|
|
|
|
|||
ortho-Phenylphenol |
|
Urine |
|
|
D |
|
|
|
|
|
|
Ethylenethio Urea (ETU) |
|
|
|
|
|
|
|
|
|
|
|
Pentachlorophenol |
|
|
|
|
|
|
|
|
|
|
|
Propylenethio Urea (PTU) |
|
|
|
|
|
|
|
|
|
|
|
Herbicides and Metabolites |
|||||||||||
Atrazine |
|
Urine |
1/3 |
1/2 |
|
|
|
|
|
|
|
Atrazine mercapturate |
|
|
|
|
|
|
|
|
|||
Desethyl atrazine |
|
|
|
|
|
|
|
|
|||
Desisopropyl atrazine |
|
|
|
|
|
|
|
|
|||
Desisopropyl atrazine mercapturate |
|
|
|
|
|
|
|
|
|
||
Diaminochloroatrazine |
|
|
|
|
|
|
|
|
|||
2,4-Dichlorophenoxyacetic acid |
|
● |
● |
● |
● |
● |
● |
|
|||
2,4,5-Trichlorophenoxyacetic acid |
|
D |
|
|
|
|
|
|
|||
Desethyl atrazine mercapturate |
|
|
|
|
|
|
|
|
|
||
N-(phosphonomethyl)glycine (Glyphosate) |
|
|
& Surplus |
Surplus |
Surplus |
|
● |
|
|||
N-Acetyl-AMPA |
|
|
|
|
Surplus |
|
● |
|
|||
N-Acetyl-glyphosate |
|
|
|
|
|
|
● |
|
|||
Aminomethlphosphonic acid (AMPA) |
|
|
Surplus |
Surplus |
|
|
D |
|
|||
Dicamba (3,6-dichloro-2-methoxybenzoic acid) |
|
|
|
|
|
|
● |
|
|||
3,6 Dichlorosalicylic acid (dicamba metabolite) |
|
|
|
|
|
|
● |
|
|||
Glufosinate (Phosphinothricin; (RS)-2-Amino-4-(hydroxy(methyl)phosphonoyl)butanoic acid) |
|
|
|
|
|
|
● |
|
|||
N-Acetyl-glufosinate (N-acetylphosphinothricin) |
|
|
|
|
|
|
● |
|
|||
3-(Methylphosphinico)propionic acid (glufosinate metabolite) |
|
|
|
|
|
|
● |
|
|||
Sulfonyl Urea Herbicides (Herbicides: Substituted Ureas) |
|
|
|
|
|
|
|
||||
Bensulfuron-methyl |
|
Urine |
1/3 |
1/2 |
|
|
|
|
|
|
|
Chlorsulfuron |
|
|
|
|
|
|
|
|
|||
Ethametsulfuron-methyl |
|
|
|
|
|
|
|
|
|||
Foramsulfuron |
|
|
|
|
|
|
|
|
|||
Halosulfuron |
|
|
|
|
|
|
|
|
|||
Mesosulfuron-methyl |
|
|
|
|
|
|
|
|
|||
Metsulfuron-methyl |
|
|
|
|
|
|
|
|
|||
Nicosulfuron |
|
|
|
|
|
|
|
|
|||
Oxasulfuron |
|
|
|
|
|
|
|
|
|||
Primisulfuron-methyl |
|
|
|
|
|
|
|
|
|||
Prosulfuron |
|
|
|
|
|
|
|
|
|||
Rimsulfuron |
|
|
|
|
|
|
|
|
|||
Sulfometuron-methyl |
|
|
|
|
|
|
|
|
|||
Sulfosulfuron |
|
|
|
|
|
|
|
|
|||
Thifensulfuron-methyl |
|
|
|
|
|
|
|
|
|||
Triasulfuron |
|
|
|
|
|
|
|
|
|||
Triflusulfuron-methyl |
|
|
|
|
|
|
|
|
|||
Insect Repellent and Metabolites |
|
|
|
|
|
|
|
|
|||
N,N-Diethyl-meta-toluamide (DEET) |
|
Urine |
1/3 |
1/2 |
● |
● |
D |
|
|
|
|
3-(Diethylcarbamoyl) benzoic acid (DEET acid/DCBA) |
|
● |
● |
● |
● |
● |
● |
|
|||
3-(Ethylcarbamoyl) benzoic acid (MEA/ECBA) |
|
|
|
|
Surplus |
● |
● |
● |
|
||
N,N-Diethyl-3-(hydroxymethyl) benzamide (Desethyl hydroxy DEET/DHMB) |
|
● |
● |
D |
|
|
|
|
|||
Neonicotinoid Insecticides |
|
|
|
|
|
|
|
|
|
|
|
Acetamiprid (ACET) |
Urine |
1/3 |
1/2 |
|
|
Surplus |
Surplus |
● |
D |
|
|
Clothianidin (CLOT) |
|
|
|
|
|
|
● |
● |
|
||
N-Desmethylacetamiprid (AND) |
|
|
|
|
|
● |
● |
|
|||
5-Hydroxyimidacloprid (OHIM) |
|
|
|
|
|
|
● |
● |
|
||
Imidacloprid (IMID) |
|
|
|
|
|
● |
D |
|
|||
Thiacloprid (THIA) |
|
|
|
|
|
● |
D |
|
|||
Clothianidin Desmethyl (CLOD) |
|
|
|
|
|
|
● |
|
|||
Clothianidin Urea (CLOU) |
|
|
|
|
|
|
● |
|
|||
Flupyradifurone (FLUP) |
|
|
|
|
|
|
|
● |
|
||
Imidacloprid Guanidine (IMIG) |
|
|
|
|
|
|
● |
|
|||
Nitenpyram Desmethyl (NITD) |
|
|
|
|
|
|
● |
|
|||
Thiamethoxam Desmethyl (TMXD) |
|
|
|
|
|
|
● |
|
|||
Sulfoxaflor 1 (SLF1) |
|
|
|
|
|
|
● |
|
|||
Sulfoxaflor 2 (SLF2) |
|
|
|
|
|
|
|
|
● |
|
|
Carbamate Pesticide Metabolites |
|
|
|
|
|
|
|
||||
Carbofuranphenol |
Urine |
1/3 |
1/2 |
|
|
|
|
|
|
|
|
2-Isopropoxyphenol |
|
|
|
|
|
|
|
||||
Organophosphorus Insecticides: Dialkyl Phosphate Metabolites |
|
|
|
|
|
|
|||||
Diethylphosphate (DEP) |
|
Urine |
1/3 |
1/2 |
● |
D |
● |
● |
● |
● |
|
Dimethylphosphate (DMP) |
|
● |
D |
● |
● |
● |
● |
|
|||
Diethylthiophosphate (DETP) |
● |
D |
● |
● |
● |
● |
|
||||
Dimethylthiophosphate (DMTP) |
|
|
● |
D |
● |
● |
● |
● |
|
||
Diethyldithiophosphate (DEDTP) |
|
● |
D |
● |
● |
● |
● |
|
|||
Dimethyldithiophosphate (DMDTP) |
|
● |
D |
● |
● |
● |
● |
|
|||
Organophosphorus Insecticides: Specific Metabolites |
|||||||||||
Acephate |
|
Urine |
1/3 |
1/2 |
|
|
|
|
|
|
|
Dimethoate |
|
|
|
|
|
|
|
|
|||
Methamidaphos |
|
|
|
|
|
|
|
|
|||
Omethoate |
|
|
|
|
|
|
|
|
|||
Malathion dicarboxylic acid |
|
● |
● |
● |
● |
● |
D |
|
|||
2-Isopropyl-4-methyl-6-hydroxypyrimidine (IMPY) |
|
● |
● |
● |
● |
● |
● |
|
|||
para-Nitrophenol |
|
|
● |
● |
● |
● |
● |
● |
|
||
3,5,6-Trichloro-2-pyridinol (TCPy) |
|
● |
● |
● |
● |
● |
● |
|
|||
2-diethylamino-6-methyl pyrimidin-4-ol |
|
|
|
|
|
|
|
|
|||
Pyrethroid Metabolites |
|
|
|
|
|
|
|
|
|||
trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (trans-DCCA) |
|
Urine |
44929 |
44928 |
● |
● |
● |
● |
● |
● |
|
cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DBCA) |
|
|
|
● |
● |
● |
● |
● |
D |
|
|
4-Fluoro-3-phenoxybenzoic acid (4F3PBA) |
|
|
|
● |
● |
● |
● |
● |
D |
|
|
3-Phenoxybenzoic acid (3PBA) |
|
|
|
● |
● |
● |
● |
● |
● |
|
|
cis-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DCCA) |
|
|
|
|
|
|
|
|
|
|
|
Organochlorine Pesticides and Metabolites |
|
|
|
|
|
|
|||||
Aldrin |
|
Serum |
1/3 |
1/2 |
|
|
|
|
|
|
|
Dieldrin |
|
|
|
|
|
|
|
|
|||
Endrin |
|
|
|
|
|
|
|
|
|||
Heptachlor Epoxide |
|
|
|
|
|
|
|
|
|||
Oxychlordane |
|
|
P |
P |
P |
● |
● |
● |
|
||
trans-Nonachlor |
|
P |
P |
P |
● |
● |
● |
|
|||
p,p'-DDT |
|
P |
P |
P |
● |
● |
● |
|
|||
p,p'-DDE |
|
P |
P |
P |
● |
● |
● |
|
|||
o,p'-DDT |
|
|
|
|
|
|
|
|
|||
Hexachlorobenzene |
|
P |
P |
P |
● |
● |
● |
|
|||
beta-Hexachlorocyclohexane |
|
|
P |
P |
P |
● |
● |
● |
|
||
gamma-Hexachlorocyclohexane |
|
P |
D |
|
|
|
|
|
|||
Mirex |
|
P |
P |
P |
● |
● |
● |
|
|||
2,4,5-Trichlorophenol |
|
Urine |
D |
|
|
|
|
|
|
||
2,4,6-Trichlorophenol |
|
D |
|
|
|
|
|
|
|||
Polybrominated Diphenyl Ethers and Brominated Biphenyl 153 |
|
|
|
|
|
||||||
2,2',4’-Tribromodiphenyl ether (BDE 17) |
|
Serum |
1/3 |
1/2 |
P |
P |
P |
● |
● |
● |
|
2,4,4’-Tribromodiphenyl ether (BDE 28) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,2’,4,4’-Tetrabromodiphenyl ether (BDE 47) |
|
|
P |
P |
P |
● |
● |
● |
|
||
2,3',4,4'-Tetrabromodiphenyl ether (BDE 66) |
|
P |
P |
P |
|
|
|
|
|||
2,2’,3,4,4’-Pentabromodiphenyl ether (BDE 85) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,2’,4,4’,5-Pentabromodiphenyl ether (BDE 99) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,2’,4,4’,6-Pentabromodiphenyl ether (BDE 100) |
P |
P |
P |
● |
● |
● |
|
||||
2,2’,4,4’,5,5’-Hexabromodiphenyl ether (BDE 153) |
|
|
P |
P |
P |
● |
● |
● |
|
||
2,2’,4,4’,5,6’-Hexabromodiphenyl ether (BDE 154) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,2’,3,4,4’,5’,6-Heptabromodiphenyl ether (BDE 183) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,2',3,3',4,4',5,5',6,6'-Decabromodiphenyl ether (BDE 209) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,2’,4,4’,5,5’-Hexabromobiphenyl (PBB 153) |
|
P |
P |
P |
● |
● |
● |
|
|||
Polychlorinated Dibenzo-p-dioxins |
|
|
|
|
|
|
|||||
1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin (HpCDD) |
Serum |
1/3 |
1/2 |
P |
P |
P |
● |
● |
● |
|
|
1,2,3,4,7,8-Hexachlorodibenzo-p-dioxin (HxCDD) |
P |
P |
P |
● |
● |
● |
|
||||
1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin (HxCDD) |
P |
P |
P |
● |
● |
● |
|
||||
1,2,3,7,8,9-Hexachlorodibenzo-p-dioxin (HxCDD) |
P |
P |
P |
● |
● |
● |
|
||||
1,2,3,4,6,7,8,9-Octachlorodibenzo-p-dioxin (OCDD) |
P |
P |
P |
● |
● |
● |
|
||||
1,2,3,7,8-Pentachlorodibenzo-p-dioxin (PeCDD) |
P |
P |
P |
● |
● |
● |
|
||||
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) |
|
|
P |
P |
P |
● |
● |
● |
|
||
Polychlorinated Dibenzofurans |
|
|
|
|
|
|
|
|
|||
1,2,3,4,6,7,8-Heptachlorodibenzofuran (HpCDF) |
Serum |
1/3 |
1/2 |
P |
P |
P |
● |
● |
● |
|
|
1,2,3,4,7,8,9-Heptachlorodibenzofuran (HpCDF) |
P |
P |
P |
● |
● |
● |
|
||||
1,2,3,4,7,8-Hexachlorodibenzofuran (HxCDF) |
|
P |
P |
P |
● |
● |
● |
|
|||
1,2,3,6,7,8-Hexachlorodibenzofuran (HxCDF) |
P |
P |
P |
● |
● |
● |
|
||||
1,2,3,7,8,9-Hexachlorodibenzofuran (HxCDF) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,3,4,6,7,8-Hexachlorodibenzofuran (HxCDF) |
|
P |
P |
P |
● |
● |
● |
|
|||
1,2,3,4,6,7,8,9-Octachlorodibenzofuran (OCDF) |
|
P |
P |
P |
● |
● |
● |
|
|||
1,2,3,7,8-Pentachlorodibenzofuran (PeCDF) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,3,4,7,8-Pentachlorodibenzofuran (PeCDF) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,3,7,8-Tetrachlorodibenzofuran (TCDF) |
P |
P |
P |
● |
● |
● |
|
||||
Dioxin-like Polychlorinated Biphenyls: Coplanar PCBs |
|
|
|
|
|
|
|
|
|||
3,4,4',5-Tetrachlorobiphenyl (PCB 81) |
Serum |
1/3 |
1/2 |
P |
P |
P |
● |
● |
● |
|
|
3,3',4,4',5-Pentachlorobiphenyl (PCB 126) |
P |
P |
P |
● |
● |
● |
|
||||
3,3',4,4',5,5'-Hexachlorobiphenyl (PCB 169) |
P |
P |
P |
● |
● |
● |
|
||||
Dioxin-like Polychlorinated Biphenyls: Mono-ortho-Substituted PCBs |
|||||||||||
2,3,3',4,4'-Pentachlorobiphenyl (PCB 105) |
|
Serum |
1/3 |
1/2 |
P |
P |
P |
● |
● |
● |
|
2,3,3',4,4'-Pentachlorobiphenyl (PCB 114) |
P |
P |
P |
● |
● |
● |
|
||||
2,3',4,4',5-Pentachlorobiphenyl (PCB 118) |
|
P |
P |
P |
● |
● |
● |
|
|||
2',3,4,4',5-Pentachlorobiphenyl (PCB 123) |
|
|
|
|
|
|
|
|
|||
2,3,3',4,4',5-Hexachlorobiphenyl (PCB 156) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,3,3',4,4',5'-Hexachlorobiphenyl (PCB 157) |
P |
P |
P |
● |
● |
● |
|
||||
2,3',4,4',5,5'-Hexachlorobiphenyl (PCB 167) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,3,3’,4,4’,5,5’-Heptachlorobiphenyl (PCB 189) |
|
P |
P |
P |
● |
● |
● |
|
|||
Polychlorinated Biphenyls: Non-Dioxin-Like |
|
|
|
|
|
|
|
||||
2,4,4'-Trichlorobiphenyl (PCB 28) |
|
Serum |
1/3 |
1/2 |
P |
P |
P |
● |
● |
● |
|
2,2'3,5'-Tetrachloro biphenyl (PCB 44) |
|
|
|
|
|
|
|
||||
2,2',4,5'-Tetrachloro biphenyl (PCB 49) |
|
|
|
|
|
|
|
|
|||
2,2',5,5'-Tetrachlorobiphenyl (PCB 52) |
|
|
|
|
|
|
|
|
|||
2,3',4,4'-Tetrachlorobiphenyl (PCB 66) |
P |
P |
P |
● |
● |
● |
|
||||
2,4,4',5-Tetrachlorobiphenyl (PCB 74) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,2’,3,4,5’-Pentachlorobiphenyl (PCB 87) |
|
|
|
|
|
|
|
||||
2,2',4,4',5-Pentachlorobiphenyl (PCB 99) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,2',4,5,5'-Pentachlorobiphenyl (PCB 101) |
|
|
|
|
|
|
|
|
|||
2,3,3’,4’,6-Pentachlorobiphenyl (PCB 110) |
|
|
|
|
|
|
|
||||
2,2',3,3',4,4'-Hexachlorobiphenyl (PCB 128) |
|
|
|
|
|
|
|
||||
2,2',3,4,4',5' and 2,3,3’,4,4’,6-Hexachlorobiphenyl (PCB 138 & 158) |
P |
P |
P |
● |
● |
● |
|
||||
2,2',3,4',5,5'-Hexachlorobiphenyl (PCB 146) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,2’,3,4’,5’,6-Hexachlorobiphenyl (PCB 149) |
|
|
|
|
|
|
|
||||
2,2’,3,5,5’,6-Hexachlorobiphenyl (PCB 151) |
|
|
|
|
|
|
|
|
|||
2,2',4,4',5,5'-Hexachlorobiphenyl (PCB 153) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,2',3,3',4,4',5-Heptachlorobiphenyl (PCB 170) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,2',3,3',4,5,5'-Heptachlorobiphenyl (PCB 172) |
|
|
|
|
|
|
|
||||
2,2',3,3',4,5',6'-Heptachlorobiphenyl (PCB 177) |
|
|
|
|
|
|
|
|
|||
2,2',3,3',5,5',6-Heptachlorobiphenyl (PCB 178) |
P |
P |
P |
● |
● |
● |
|
||||
2,2',3,4,4',5,5'-Heptachlorobiphenyl (PCB 180) |
P |
P |
P |
● |
● |
● |
|
||||
2,2',3,4,4',5',6-Heptachlorobiphenyl (PCB 183) |
P |
P |
P |
● |
● |
● |
|
||||
2,2',3,4',5,5',6-Heptachlorobiphenyl (PCB 187) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,2’,3,3’,4,4’,5,5’-Octachlorobiphenyl (PCB 194) |
|
P |
P |
P |
● |
● |
● |
|
|||
2,2’,3,3’,4,4’,5,6-Octachlorobiphenyl (PCB 195) |
|
|
|
|
|
|
● |
|
|||
2,2’,3,3’,4,4’,5,6’ and 2,2’,3,4,4’,5,5’,6-Octachlorobiphenyl (PCB 196 & 203) |
P |
P |
P |
● |
● |
● |
|
||||
2,2’,3,3’,4,5,5’,6-Octachlorobiphenyl (PCB 199) |
P |
P |
P |
● |
● |
● |
|
||||
2,2’,3,3’,4,4’,5,5’,6-Nonachlorobiphenyl (PCB 206) |
|
|
P |
P |
P |
● |
● |
● |
|
||
2,2',3,3',4,4',5,5',6,6'-Decachloro biphenyl (PCB 209) |
|
P |
P |
P |
● |
● |
● |
|
|||
Perfluoroalkyl and Polyfluoroalkyl Substances: Surfactants |
|||||||||||
Perfluorobutane sulfonic acid (PFBS) |
|
Serum |
1/3 |
1/2 |
● |
& Surplus |
D |
|
|
|
|
Pefluorodecanoic acid (PFDA) |
|
● |
& Surplus |
● |
● |
● |
● |
|
|||
Perflurododecanoic acid (PFDoA) |
● |
& Surplus |
● |
D |
|
|
|
||||
Perfluoroheptanoic acid (PFHpA) |
|
|
● |
& Surplus |
D |
|
|
|
|
||
Perfluorohexane sulfonic acid (PFHxS) |
|
● |
& Surplus |
● |
● |
● |
● |
|
|||
Perfluorononanoic acid (PFNA) |
|
|
● |
& Surplus |
● |
● |
● |
● |
|
||
Perfluorooctanoic acid (PFOA) |
|
● |
& Surplus |
|
|
|
|
|
|||
n-Perfluorooctanoic acid (n-PFOA) |
|
& Surplus |
● |
● |
● |
● |
|
||||
Branched Perfluorooctanoic acid isomers (Sb-PFOA)* |
|
Surplus |
● |
● |
● |
● |
|
||||
Perfluorooctane sulfonic acid (PFOS) |
● |
● |
|
|
|
|
|
||||
n-Perfluorooctane sulfonic (n-PFOS) |
|
|
|
● Surplus |
● |
● |
● |
● |
|
||
Perfluoromethylheptane sulfonic acid isomers (Sm-PFOS)* |
|
|
|
● |
● |
● |
● |
|
|||
Perfluorooctane sulfonamide (PFOSA or FOSA) |
|
|
● |
|
|
|
|
|
|
||
Perfluoroheptanesulfooic acid (PFHpS) |
|
|
|
|
& Surplus |
D |
|
|
|||
Perfluorohexanoic acid (PFHxA) |
|
|
|
|
Surplus |
D |
|
|
|||
9-Chlorohexadecafluoro-3-oxanonane-1-sulfonic acid (9Cl-PF3ONS) |
|
|
|
|
|
D |
|
|
|||
Adona (4,8-dioxa-3H-perfluorononanoic acid) (ADONA) |
|
|
|
|
D |
|
|
||||
GenX ( 2,3,3,3-tetrafluoro-2-(1,1,2,2,3,3,3-heptafluoropropoxy)-propanoic acid (HFPO-DA)) |
|
|
|
|
D |
|
|
||||
2-(N-Ethyl-perfluorooctane sulfonamido) acetic acid (EtFOSAA) |
● |
Surplus |
|
|
|
|
|
||||
2-(N-Methyl-perfluorooctane sulfonamido) acetic acid (MeFOSAA) |
● |
|
● |
● |
● |
● |
|
||||
Perfluoroundecanoic acid (PFUA or PFUnDA) |
● |
|
● |
● |
● |
● |
|
||||
Perfluoroalkyl and Polyfluoroalkyl Substances: Urine |
|||||||||||
Perfluorobutanoic acid (PFBA) |
Urine |
1/3 |
1/2 |
|
& Surplus |
|
Surplus |
D |
|
|
|
PFBS |
|
|
|
|
|
|
|
|
|
|
|
PFDA |
|
|
|
|
|
|
|
|
|
|
|
Perfluoroheptane sulfonic acid (PFHpS) |
1/3 |
1/2 |
|
|
|
Surplus |
D |
● |
|
||
PFHpA |
|
|
|
|
|
|
|
|
|
|
|
PFHxS |
|
|
|
|
|
|
|
|
|
|
|
Perfluorohexanoic acid (PFHxA) |
1/3 |
1/2 |
|
|
|
Surplus |
D |
● |
|
||
PFNA |
|
|
|
|
|
|
|
|
|
|
|
n-PFOA |
|
|
|
|
|
|
|
|
|
|
|
Sb-PFOA |
|
|
|
|
|
|
|
|
|
|
|
n-PFOS |
|
|
|
|
|
|
|
|
|
|
|
Sm-PFOS |
|
|
|
|
|
|
|
|
|
|
|
Perfluoropentanoic acid (PFPeA) |
1/3 |
1/2 |
|
|
|
Surplus |
D |
|
|
||
PFUnDA |
|
|
|
|
|
|
|
|
|
|
|
9-Chlorohexadecafluoro-3-oxanonane-1-sulfonic acid (9Cl-PF3ONS) |
1/3 |
1/2 |
|
|
|
Surplus |
D |
|
|
||
Adona (4,8-dioxa-3H-perfluorononanoic acid) (ADONA) |
|
|
|
|
|
Surplus |
D |
|
|
||
GenX ( 2,3,3,3-tetrafluoro-2-(1,1,2,2,3,3,3-heptafluoropropoxy)-propanoic acid (HFPO-DA)) |
|
|
|
|
|
Surplus |
D |
|
|
||
Phthalate and Phthalate Alternative Metabolites |
|||||||||||
Mono-benzyl phthalate (MBzP) |
|
Urine |
1/3 |
1/2 |
● |
● |
● |
● |
● |
● |
|
Mono-2-hydroxybutyl phthalate (MHBP) |
|
Surplus |
● |
● |
● |
● |
|
||||
Mono-n-butyl phthalate (MnBP) |
|
● |
● |
● |
● |
● |
● |
|
|||
Mono-iso-butyl phthalate (MiBP) |
● |
● |
● |
● |
● |
● |
|
||||
Mono-2-hydroxyisobutyl phthalate (MHiBP) |
|
Urine |
|
& Surplus |
& Surplus |
& Surplus |
● |
● |
|
||
Mono-cyclohexyl phthalate (MCHP) |
|
D |
|
|
|
|
|
|
|||
Mono-ethyl phthalate (MEP) |
|
● |
● |
● |
● |
● |
● |
|
|||
Mono-2-ethylhexyl phthalate (MEHP) |
● |
● |
● |
● |
● |
● |
|
||||
Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) |
|
● |
● |
● |
● |
● |
● |
|
|||
Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) |
● |
● |
● |
● |
● |
● |
|
||||
Mono-(2-ethyl-5-carboxypentyl) phthalate (MECPP) |
|
● |
● |
● |
● |
● |
● |
|
|||
Mono-carboxyisononyl phthalate (MCNP) |
|
● |
● |
● |
● |
● |
● |
|
|||
Mono-oxoisodecyl phthalate (MODP) |
|
|
WD |
WD |
D |
|
|
||||
Mono-isononyl phthalate (MiNP) |
● |
● |
● |
● |
D |
|
|
||||
Mono-oxoisononyl phthalate (MONP) |
|
|
|
& Surplus |
& Surplus |
● |
● |
|
|||
Mono-carboxyisoctyl phthalate (MCOP) |
● |
● |
● |
● |
● |
● |
|
||||
Mono-methyl phthalate (MMP) |
|
● |
D |
|
|
|
|
|
|||
Mono-(3-carboxypropyl) phthalate (MCPP) |
● |
● |
● |
● |
● |
● |
|
||||
Mono-n-octyl phthalate (MOP) |
|
D |
|
|
|
|
|
|
|||
Cyclohexane 1,2-dicarboxylic acid mono hydroxy isononyl ester (MHNCH®) |
● |
● |
● |
● |
● |
● |
|
||||
Cyclohexane-1,2-dicarboxylic acid-mono(carboxyoctyl) ester (MCOCH) |
|
|
WD |
● |
● |
● |
● |
|
|||
Mono (2-ethyl-5-carboxypentyl) terephthalate (MECPTP) |
|
|
& Surplus |
& Surplus |
● |
● |
|
||||
Mono (2-ethyl-5-hydroxyhexyl) terephthalate (MEHHTP) |
|
|
& Surplus |
& Surplus |
● |
● |
|
||||
Polycyclic Aromatic Hydrocarbon Metabolites |
|
|
|
|
|
||||||
2-Hydroxyfluorene |
Urine |
1/3 |
1/2 |
● |
● |
● |
● |
● |
● |
|
|
3-Hydroxyfluorene |
● |
● |
● |
● |
● |
● |
|
||||
9-Hydroxyfluorene |
● |
D |
|
|
|
|
|
||||
1-Hydroxyphenanthrene |
● |
● |
● |
● |
● |
● |
|
||||
2-Hydroxyphenanthrene |
● |
D |
|
|
|
|
|
||||
3-Hydroxyphenanthrene |
● |
D |
|
|
|
|
|
||||
2- & 3-Hydroxyphenanthrene |
|
● |
● |
● |
● |
● |
|
||||
4-Hydroxyphenanthrene |
● |
D |
|
|
|
|
|
||||
1-Hydroxypyrene |
● |
● |
● |
● |
● |
● |
|
||||
1-Hydroxynapthalene (1-Naphthol) |
● |
● |
● |
● |
● |
● |
|
||||
2-Hydroxynapthalene (2-Naphthol) |
● |
● |
● |
● |
● |
● |
|
||||
Phenylpyrazole insecticides (fipronil) |
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||||
Anabasine, Total |
|
Urine |
3–5 & 1/3 of 6+ |
3–4 & 1/2 of 5+ |
|
● |
● |
● |
● |
● |
|
Anatabine, Total |
|
|
● |
● |
● |
● |
● |
|
|||
Cotinine |
Serum |
3+ |
2+ |
● |
● |
● |
● |
● |
● |
|
|
Cotinine, Total |
|
Urine |
3–5 & 1/3 of 6+ |
3–4 & 1/2 of 5+ |
|
● |
● |
● |
● |
● |
|
Cotinine N-Oxide, Total |
|
|
● |
● |
● |
● |
● |
|
|||
trans-3'-Hydroxycotinine, Total |
Serum |
3+ |
2+ |
|
● |
● |
● |
● |
● |
|
|
trans-3'-Hydroxycotinine, Total |
Urine |
3–5 & 1/3 of 6+ |
3–4 & 1/2 of 5+ |
|
● |
● |
● |
● |
● |
|
|
|
|
|
|
|
|
|
|
|
|
||
1-(3-Pyridyl)-1-butanol-4-carboxylic acid |
|
|
WD |
● |
● |
● |
● |
|
|||
Nicotine |
|
|
|
● |
● |
● |
● |
● |
|
||
Nicotine 1'-Oxide, Total |
|
|
● |
● |
● |
● |
● |
|
|||
Nornicotine |
|
|
|
● |
● |
● |
● |
● |
|
||
Tobacco Biomarkers: Tobacco-specific Nitrosamines (TSNAs) |
|
|
|
|
|
|
|
||||
N'-Nitrosoanabasine (NAB) |
Urine |
3–5 & 1/3 of 6+ |
3–4 & 1/2 of 5+ |
|
● |
WD |
WD |
WD |
WD |
|
|
N'-Nitrosoanatabine (NAT) |
|
● |
WD |
WD |
WD |
WD |
|
||||
N'-Nitrosonornicotine (NNN) |
|
● |
WD |
WD |
WD |
WD |
|
||||
4-(Methylnitrosamino)-1-(3-pyridyl)-1-Butanol (NNAL) |
● |
● |
● |
● |
● |
● |
|
||||
|
|
WD |
WD |
WD |
WD |
WD |
|
||||
Tobacco Biomarkers: Volatile N-Nitrosamines |
|
|
|
|
|
|
|||||
N-Nitrosodiethylamine (NDEA) |
Urine |
1/3 |
1/2 |
|
● |
WD |
D |
D |
D |
|
|
N-nitrosodimethylamine (NDMA) |
|
WD |
WD |
D |
D |
D |
|
||||
N-Nitrosoethylmethylamine (NMEA) |
|
● |
WD |
D |
D |
D |
|
||||
N-nitrosomorpholine (NMOR) |
|
● |
WD |
D |
D |
D |
|
||||
N-Nitrosopiperidine (NPIP) |
|
● |
WD |
D |
D |
D |
|
||||
N-Nitrosopyrrolidine (NPYR) |
|
● |
WD |
D |
D |
D |
|
||||
Disinfection Byproducts - Volatile Organic Compounds (VOCs) - Trihalomethanes & MTBE (IN WATER) |
|
|
|
|
|||||||
Bromodichloromethane |
Water |
1/3 |
1/2 |
D |
|
|
|
|
|
|
|
Dibromochloromethane (Chlorodibromomethane) |
D |
|
|
|
|
|
|
||||
Tribromomethane (Bromoform) |
D |
|
|
|
|
|
|
||||
Trichloromethane (Chloroform) |
D |
|
|
|
|
|
|
||||
Methyl tert-butyl ether (MTBE) |
D |
|
|
|
|
|
|
||||
Disinfection Byproducts - Volatile Organic Compounds (VOCs) - Trihalomethanes & MTBE |
|
||||||||||
Bromodichloromethane |
Whole Blood |
1/2 of 12+ |
1/2 of 12+ |
● |
● |
● |
● |
● |
● |
|
|
Dibromochloromethane (Chlorodibromomethane) |
● |
● |
● |
● |
● |
● |
|
||||
Tribromomethane (Bromoform) |
● |
● |
● |
● |
● |
● |
|
||||
Trichloromethane (Chloroform) |
● |
● |
● |
● |
● |
● |
|
||||
Perchlorate and Other Anions |
|
||||||||||
Nitrate |
|
Urine |
1/3 |
1/2 |
● |
● |
● |
● |
● |
● |
|
Perchlorate |
|
|
|
● |
● |
● |
● |
● |
● |
|
|
Thiocyanate |
|
|
|
● |
● |
● |
● |
● |
● |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tobacco Biomarkers: Heterocyclic Amines |
|
|
|
|
|||||||
3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1) |
Urine |
1/3 |
1/2 |
|
● |
D |
WD |
WD |
D |
|
|
2-Amino-3-methyl-9H-pyriodo[2,3-b]indole (MeA-α-C) |
|
● |
D |
WD |
WD |
D |
|
||||
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) |
|
● |
D |
WD |
WD |
D |
|
||||
2-Amino-9H-pyrido[2,3-b]indole (A-α-C) |
|
● |
D |
WD |
WD |
D |
|
||||
2-Amino-3-methyl-3H-imidazo[4,5-f]quinolone (IQ) |
|
● |
D |
WD |
WD |
D |
|
||||
2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P1) |
|
● |
D |
WD |
WD |
D |
|
||||
2-Aminodipyrido[1,2-a:3',2'-d] imidazole (Glu-P2) |
|
● |
D |
WD |
WD |
D |
|
||||
1-Methyl-9H-pyrido[3,4-]indole (Harman) |
|
|
● |
D |
WD |
WD |
D |
|
|||
1-Methyl-3-amino-5H-pyrido[4,3-b]indole (Trp-P-2) |
|
● |
D |
WD |
WD |
D |
|
||||
9H-Pyrido[3,4-]indole (Norharman) |
|
|
● |
D |
WD |
WD |
D |
|
|||
Volatile Organic Compounds (VOCs) |
|
|
|
|
|
|
|
||||
1,1,1-Trichloroethane (Methyl chloroform) |
Whole Blood |
1/2 of 12+ |
1/2 of 12+ |
● |
● |
● |
● |
● |
● |
● |
|
1,1,1,2-Tetrachloroethane |
● |
● |
● |
● |
● |
D |
|
||||
1,1,2,2-Tetrachloroethane |
● |
D |
|
|
|
|
|
||||
1,1,2-Trichloroethane |
● |
D |
|
|
|
|
|
||||
1,2,3-Trichloropropane |
● |
● |
● |
● |
● |
● |
● |
||||
1,1-Dichloroethane |
● |
D |
|
|
|
|
|
||||
1,1-Dichloroethene (Vinylidene chloride) |
● |
D |
|
|
|
|
|
||||
1,2-Dibromo-3-chloropropane (DBCP) |
D |
|
|
|
|
|
|
||||
1,2-Dibromoethane |
|
|
● |
● |
● |
● |
● |
D |
|
||
1,2-Dichlorobenzene |
|
● |
● |
● |
● |
● |
● |
● |
|||
1,2-Dichloroethane (Ethylene dichloride) |
|
● |
● |
● |
● |
● |
● |
● |
|||
cis-1,2-Dichloroethene |
|
● |
D |
|
|
|
|
|
|||
trans--1,2-Dichloroethylene |
|
● |
D |
|
|
|
|
|
|||
1,2-Dichloropropane |
Whole Blood |
● |
D |
|
|
|
|
|
|||
1,3-Dichlorobenzene |
|
● |
● |
● |
● |
● |
● |
● |
|||
1,4-Dichlorobenzene (p-Dichlorobenzene) |
|
● |
● |
● |
● |
● |
● |
● |
|||
1,4-Dioxane |
|
● |
● |
● |
WD |
D |
|
|
|||
1-Bromopropane/Propyl bromide |
|
WD |
D |
|
|
|
|
||||
2,5-Dimethylfuran |
|
● |
● |
● |
● |
● |
● |
● |
|||
2-Hexanone |
|
|
|
|
|
WD |
● |
● |
|||
Benzene |
|
● |
● |
● |
● |
● |
● |
● |
|||
Benzonitrile |
|
|
WD |
● |
● |
● |
● |
● |
|||
Chlorobenzene (Monochlorobenzene) |
● |
● |
● |
● |
● |
● |
● |
||||
Chloroethane |
|
|
● |
● |
● |
● |
● |
● |
|||
Cyclohexane |
|
|
● |
● |
● |
● |
● |
● |
|||
Dibromomethane |
|
● |
D |
|
|
|
|
|
|||
Dichloromethane (Methylene chloride) |
● |
● |
● |
● |
● |
● |
● |
||||
Diethyl ether |
|
● |
● |
● |
● |
● |
● |
||||
Ethyl acetate |
|
|
● |
● |
● |
● |
● |
● |
|||
Ethylbenzene |
|
● |
● |
● |
● |
● |
● |
● |
|||
Furan |
|
● |
● |
● |
● |
● |
● |
● |
|||
n-Heptane |
|
|
● |
● |
● |
● |
● |
● |
|||
Hexachloroethane |
|
● |
D |
|
|
|
|
|
|||
n-Hexane |
|
● |
● |
● |
● |
● |
● |
● |
|||
Isobutyronitrile |
|
|
WD |
● |
● |
● |
● |
● |
|||
Isopropylbenzene (Cumene) |
|
● |
● |
● |
● |
● |
● |
● |
|||
Methyl tert-butyl ether (MTBE) |
● |
● |
● |
● |
● |
● |
● |
||||
Methylcyclopentane |
|
|
|
● |
● |
● |
● |
● |
● |
||
Methyl isobutyl ketone |
|
|
WD |
WD |
● |
● |
● |
● |
|||
Nitrobenzene |
|
● |
● |
● |
● |
● |
D |
|
|||
Nitromethane |
|
● |
D |
|
|
|
|
|
|||
n-Octane |
|
|
● |
● |
● |
● |
● |
● |
|||
Styrene |
Whole Blood |
X1 |
X1 |
X1 |
X1 |
X1 |
● |
● |
|||
Tetrachloroethene (Perchloroethylene) |
● |
● |
● |
● |
● |
● |
● |
||||
Tetrachloromethane (Carbon tetrachloride) |
● |
● |
● |
● |
● |
● |
● |
||||
Tetrahydrofuran |
|
|
● |
● |
● |
● |
● |
● |
|||
Toluene |
X1 |
● |
● |
X1 |
X1 |
● |
● |
||||
Trichloroethene (Trichloroethylene) |
● |
● |
● |
● |
● |
● |
● |
||||
α,α,α-Trifluorotoluene |
|
● |
● |
● |
● |
D |
|
||||
Vinyl bromide |
|
|
● |
● |
● |
● |
D |
|
|||
m-/p-Xylene |
|
● |
● |
● |
● |
● |
● |
● |
|||
o-Xylene |
● |
● |
● |
● |
● |
● |
● |
||||
α-Pinene |
|
|
|
|
● |
● |
● |
||||
Volatile Organic Compound Metabolites (VOC metabolites) |
|||||||||||
N-Acetyl-S- (2-carboxyethyl)-L-cysteine (CEMA) |
Urine |
1/3 |
3–4 & 1/2 of 5+ |
● |
● |
● |
● |
● |
● |
● |
|
N-Acetyl-S- (3-hydroxypropyl)-L-cysteine (HPMA) |
|
● |
● |
● |
● |
● |
● |
● |
|||
N-Acetyl-S-(2-carbamoylethyl)-L-cysteine (AAMA) |
|
● |
● |
● |
● |
● |
● |
● |
|||
N-Acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine (GAMA) |
● |
● |
● |
● |
● |
● |
● |
||||
N-Acetyl-S-(1-cyano-2-hydroxyethyl)-L-cysteine |
|
|
● |
● |
● |
● |
● |
||||
N-Acetyl-S-(2-cyanoethyl)-L-cysteine (CYMA) |
● |
● |
● |
● |
● |
● |
● |
||||
N-Acetyl-S- (2-hydroxyethyl)-L-cysteine (HEMA) |
● |
● |
● |
● |
● |
● |
● |
||||
N-Acetyl-S-(phenyl)-L-cysteine (PMA) |
● |
● |
● |
D |
|
|
|
||||
N-Acetyl-S-(n-propyl)-L-cysteine (BPMA) |
● |
● |
● |
● |
● |
● |
● |
||||
N-Acetyl-S- (3,4-dihydroxybutyl)-L-cysteine (DHBM) |
● |
● |
● |
● |
● |
● |
● |
||||
N-Acetyl-S- (1-hydroxymethyl-2-propenyl)-L-cysteine (MHB1) |
● |
● |
● |
D |
|
|
|
||||
N-Acetyl-S- (2-hydroxy-3-butenyl)-L-cysteine (MHB2) |
● |
● |
● |
D |
|
|
|
||||
N-Acetyl-S-(2-hydroxy-3-methyl-3-buten-1-yl)-L-cysteine + N-Acetyl-S-[1-(hydroxymethyl)-2-methyl-2-propen-1-yl]-L-cysteine |
|
WD |
● |
D |
|
|
|
||||
N-Acetyl-S- (4-hydroxy-2-butenyl)-L-cysteine (MHB3) |
● |
● |
● |
● |
● |
● |
● |
||||
N-Acetyl-S-(4-hydroxy-2-methyl-2 buten-1-yl)-L-cysteine |
|
|
● |
● |
● |
● |
● |
||||
2-Thioxothiazolidine-4-carboxylic acid (TTCA) |
● |
● |
WD |
● |
● |
● |
● |
||||
N-Acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine (HPMM) |
|
Urine |
● |
● |
● |
● |
● |
● |
● |
||
2-Aminothiazoline-4-carboxylic acid (ATCA) |
|
● |
● |
● |
● |
● |
● |
● |
|||
N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine (AMCA) |
|
● |
● |
● |
● |
● |
● |
● |
|||
Phenylglyoxylic acid (PHGA) |
|
● |
● |
● |
● |
● |
● |
● |
|||
N-Acetyl-S- (2-hydroxypropyl)-L-cysteine (HPM2) |
● |
● |
● |
● |
● |
● |
● |
||||
N-Acetyl-S-(1-phenyl-2-hydroxyethyl)-L-cysteine + N-Acetyl-S-(2-phenyl-2-hydroxyethyl)-L-cysteine (PHEM) |
● |
● |
● |
● |
● |
● |
● |
||||
Mandelic acid (MADA) |
|
● |
● |
● |
● |
● |
● |
● |
|||
N-Acetyl-S-(trichlorovinyl)-L-cysteine (TCVM) |
|
● |
● |
● |
D |
|
|
|
|||
N-Acetyl-S-(benzyl)-L-cysteine (BMA) |
● |
● |
● |
● |
● |
● |
● |
||||
N-Acetyl-S-(1,2-dichlorovinyl)-L-cysteine (1DCV) |
|
● |
● |
● |
D |
|
|
|
|||
N-Acetyl-S-(2,2-dichlorovinyl)-L-cysteine (2DCV) |
● |
● |
● |
D |
|
|
|
||||
N-Acetyl-S-(dimethylphenyl)-L-cysteine (DPMA) |
● |
● |
● |
D |
|
|
|
||||
2-Methylhippuric acid (2MHA) |
● |
● |
● |
● |
● |
● |
● |
||||
3- & 4-Methylhippuric acid (34MH) |
● |
● |
● |
● |
● |
● |
● |
||||
MMA N-Acetyl-S-methyl-L-cysteine |
3–4, 1/2 of 5+ |
|
|
|
|
|
|
● |
|||
PPMA N-Acetyl-S-(6-hydroxy-2,4-cyclohexadiene-1-yl)-L-cysteine) |
|
|
|
|
|
|
● |
||||
|
1/3 |
1/2 |
WD |
WD |
WD |
D |
|
|
|
||
|
|
|
|
|
|
|
|
||||
Aldehydes |
|
|
|
|
|
|
|
|
|
|
|
Acetaldehyde |
Serum |
1/3 of smokers |
1/2 of smokers |
|
|
D |
|
|
|
|
|
Acrolein |
|
|
|
D |
|
|
|
|
|||
Benzaldehyde |
|
|
● |
D |
|
|
|
|
|||
Butyraldehyde |
|
|
● |
D |
|
|
|
|
|||
Crotonaldehyde |
|
|
● |
D |
|
|
|
|
|||
Decanaldehyde |
|
|
● |
D |
|
|
|
|
|||
Furaldehyde |
|
|
|
D |
|
|
|
|
|||
Heptanaldehyde |
|
|
● |
D |
|
|
|
|
|||
Hexanaldehyde |
|
|
● |
D |
|
|
|
|
|||
Isobutyraldehyde |
|
|
D |
|
|
|
|
||||
Isopentanaldehyde |
|
● |
D |
|
|
|
|
||||
Nonanaldehyde |
|
|
● |
D |
|
|
|
|
|||
Octanaldehyde |
|
|
● |
D |
|
|
|
|
|||
Pentanaldehyde |
|
|
● |
D |
|
|
|
|
|||
Propanaldehyde |
|
|
● |
D |
|
|
|
|
|||
o-Tolualdehyde |
|
|
● |
D |
|
|
|
|
|||
trans-Hexanal |
|
|
|
D |
|
|
|
|
|||
trans-Octenal |
|
|
|
D |
|
|
|
|
|||
trans-Nonenal |
|
|
|
D |
|
|
|
|
|||
Tobacco Biomarkers: Aromatic Amines (TVB) |
|
|
|
|
|
|
|
|
|
||
4-Aminobiphenyl |
Urine |
1/3 |
1/2 |
|
● |
WD |
WD |
WD |
D |
|
|
1-Aminonaphthalene |
|
|
WD |
WD |
WD |
D |
|
||||
2-Aminonaphthalene |
|
● |
WD |
WD |
WD |
D |
|
||||
o-Anisidine |
|
● |
WD |
WD |
WD |
D |
|
||||
2,6-Dimethylaniline |
|
● |
WD |
WD |
WD |
D |
|
||||
o-Toluidine |
|
● |
WD |
WD |
WD |
D |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
Urinary Aromatic Diamines (formerly Diisocyanate metabolites and urinary amines) |
|||||||||||
4,4'-Diaminodiphenylmethane (4MDA) |
Urine |
|
|
Surplus |
|
● |
D |
|
|
|
|
1,5-Diaminonaphthalene (5NDA) |
|
|
|
|
● |
D |
|
|
|
||
2,4-Diaminotoluene (4TDA) |
|
|
|
|
● |
D |
|
|
|
||
2,6-Diaminotoluene (6TDA) |
|
|
|
|
● |
D |
|
|
|
||
p-Phenylenediamine (PPDA) |
|
|
|
|
● |
D |
|
|
|
||
o-Phenylenediamine (OPDA) |
|
|
Surplus |
|
WD |
D |
|
|
|
||
|
|
|
|
|
WD |
● |
● |
|
|
||
|
|
|
|
|
WD |
● |
● |
|
|
||
|
|
|
|
|
WD |
● |
● |
|
|
||
|
|
|
|
|
WD |
● |
● |
|
|
||
Benzene Metabolites (VOC metabolites II) |
|
||||||||||
N-2-Furoylglycine (N2FG) |
Urine |
1/3 |
1/2 |
|
|
|
Surplus |
|
● |
|
|
5-Hydroxymethyl-2-furancarboxylic acid (HMFA) |
|
|
|
Surplus |
|
● |
|
||||
2,5-Furandicarboxylic acid (FDCA) |
|
|
|
Surplus |
|
|
|
||||
5-Hydroxymethyl-2-furoylglycine (HMFG) |
|
|
|
Surplus |
|
● |
|
||||
N-Acetyl-S-(phenyl)-L-cysteine (PMA/PHMA) |
3–4 & 1/2 of 5+ |
|
|
|
Surplus |
● |
● |
● |
|||
t,t-Muconic acid (MUCA)/Muconic acid (MUCA) |
|
|
|
Surplus |
● |
● |
● |
||||
5-Hydroxy-N-methyl-2-pyrrolidone (5HMP) |
|
|
|
WD |
|
|
|
||||
Terpenes in Serum (Terpenes) |
|||||||||||
α-Pinene (SAPN) |
Serum |
1/2 of 5+ |
1/2 of 5+ |
|
Surplus |
|
|
|
● |
● |
|
β-Pinene (SBPN) |
|
|
|
|
|
● |
● |
||||
β-Myrcene (SBMY) |
|
Surplus |
|
|
|
● |
|
||||
Δ-3-Carene (SD3C) |
|
|
|
|
|
● |
|
||||
d-Limonene (SLIM) |
|
Surplus |
|
|
|
● |
● |
||||
β-Caryophyllene (SBCP) |
|
Surplus |
|
|
|
● |
|
||||
α-Humulene (SAHU) |
|
WD |
|
|
|
● |
|
8-
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Touarti, Christina |
File Modified | 0000-00-00 |
File Created | 2024-10-28 |